EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

Janiece S Glover, Romney Humphries iD

Clinical Chemistry · 06.07.2026 · 72 (7) · 745-755

DOI: 10.1093/clinchem/hvag033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Chemistry, online erschienen am 24.04.2026. Verfasst von Janiece S Glover und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents, Clinical Decision-Making. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Antimicrobial resistance (AMR) is a critical global health challenge, underscoring the need for diagnostic innovations that enable timely, and targeted therapy. Rapid phenotypic antimicrobial susceptibility testing (AST) offers a transformative approach by delivering actionable susceptibility results significantly earlier than conventional methods. This accelerated turnaround is vital for optimizing antibiotic therapy and improving outcomes in severe infections, such as sepsis, where delays in effective treatment increase morbidity and mortality. Despite these advantages, implementation faces challenges, including variability in test performance, lack of standardized protocols, and cost–benefit considerations. Content This review provides an overview of emerging rapid phenotypic AST technologies, focusing on their clinical relevance and operational implications. We outline the fundamentals of the phenotypic approach, highlight growth-based methods, and summarize evidence, demonstrating the impact of rapid phenotypic AST on reducing time to effective therapy and supporting antimicrobial stewardship. Summary Rapid phenotypic AST represents a pivotal advancement in combating AMR, offering the potential to bridge diagnostic gaps and enhance patient outcomes through timely, evidence-based antimicrobial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipAnti-Bacterial AgentsClinical Decision-MakingHumansMicrobial Sensitivity TestsPhenotypeDrug Resistance, BacterialRapid Diagnostic Tests

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.

ORCID-Profile: Romney Humphries

Zitieren

APA

Glover, J. S., & Humphries, R. (2026). Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making. Clinical Chemistry, 72(7), 745-755. https://doi.org/10.1093/clinchem/hvag033

Vancouver

Glover JS, Humphries R. Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making. Clinical Chemistry. 2026;72(7):745-755. doi:10.1093/clinchem/hvag033

BibTeX
@article{Glover2026,
  author = {Glover, Janiece S and Humphries, Romney},
  title = {Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making},
  journal = {Clinical Chemistry},
  year = {2026},
  volume = {72},
  number = {7},
  pages = {745--755},
  doi = {10.1093/clinchem/hvag033}
}
Kostenlos starten →